Generics· August 25, 2026 · 18 min read
Dasynoc's CRL Is a Facility Letter: Nine AB Generics and Phyrago Occupy Access
By Ran Chen#Generics#505(b)(2)#Orange Book
Topic
FDA CRL
FDA Complete Response Letters, non-approval decision themes, manufacturing inspection observations, and resubmission timelines.
Specialty· August 6, 2026 · 13 min read
Gout Treatment Access Landscape: Generic ULT to Krystexxa
By Ran Chen#Gout#Krystexxa#allopurinol